Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Drug Discovery Today|October 4, 2016
Cyclooxygenase-2 in glioblastoma multiformeJiange Qiu, Zhi Shi, Jianxiong JiangExpert Review of Neurotherapeutics|December 23, 2015
Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticusYifeng Du, Timothy Kemper, Jiange Qiu, et al.Trends in Cancer|July 19, 2017
Prostaglandin E2 Signaling: Alternative Target for Glioblastoma?Jianxiong Jiang, Jiange Qiu, Qianqian Li, et al.Trends in Pharmacological Sciences|April 11, 2016
Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to BedsideAvijit Dey, Xu Kang, Jiange Qiu, et al.Biotechnology Advances|December 3, 2014
Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancerShengpeng Wang, Jiange Qiu, Zhi Shi, et al.Medicinal Research Reviews|December 23, 2016
Recent Advances in Anticancer Activities and Drug Delivery Systems of TanninsYuee Cai, Jinming Zhang, Nelson G Chen, et al.Current Cancer Drug Targets|May 23, 2024
LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma ProgressionDute Gao, Huahu Guo, Zhaochen Liu, et al.British Journal of Pharmacology|May 26, 2023
Complementary roles of EP2 and EP4 receptors in malignant gliomaJiange Qiu, Qianqian Li, Junqi Li, et al.Scientific Reports|August 27, 2017
Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtypeXu Kang, Jiange Qiu, Qianqian Li, et al.British Journal of Pharmacology|February 15, 2019
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growthJiange Qiu, Qianqian Li, Katherine A Bell, et al.Pageof 2